Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Revenue (2018 - 2025)

Historic Revenue for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $20.7 million.

  • Bio's Revenue rose 913.65% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.1 million, marking a year-over-year increase of 1224.49%. This contributed to the annual value of $69.3 million for FY2024, which is 1855.68% up from last year.
  • Bio's Revenue amounted to $20.7 million in Q3 2025, which was up 913.65% from $20.2 million recorded in Q2 2025.
  • In the past 5 years, Bio's Revenue registered a high of $20.7 million during Q3 2025, and its lowest value of $5.9 million during Q1 2021.
  • Moreover, its 5-year median value for Revenue was $14.5 million (2023), whereas its average is $13.6 million.
  • Its Revenue has fluctuated over the past 5 years, first soared by 11551.18% in 2021, then skyrocketed by 382.99% in 2024.
  • Quarter analysis of 5 years shows Bio's Revenue stood at $8.4 million in 2021, then skyrocketed by 38.79% to $11.6 million in 2022, then surged by 46.26% to $17.0 million in 2023, then rose by 3.83% to $17.6 million in 2024, then increased by 17.22% to $20.7 million in 2025.
  • Its Revenue stands at $20.7 million for Q3 2025, versus $20.2 million for Q2 2025 and $18.5 million for Q1 2025.